Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Two neighboring Texas towns face a high-stakes fight over a proposed $10 billion AI data center, pitting rural govern...
Rivian CEO RJ Scaringe has signaled that rivian scaringe wants company to be judged by software and ecosystem, not ju...
XRP’s on-chain activity has cooled to a rare lull even as the price slips. New wallet signups and active addresses re...
Tim Cook discusses the moment he took the reins from Steve Jobs and the founder's advice to pursue the right path for...
Tesla's stock has traded with unusual calm as the company advances robotaxis and semiconductor initiatives. Early pil...
Super Micro Computer faces a looming risk of removal from the S&P 500 after prosecutors charged its co-founder and tw...
GLD reached a milestone in March 2026, crossing $180 billion in assets under management as gold-backed ETFs attract r...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Bitcoin fell to the $75,000 area after a volatile week of gains and selling. On-chain flows, high-profile bets, and F...
MicroStrategy is pursuing a sizable buyback of zero-coupon convertible notes, a move some critics say reveals liquidi...
Lucid stock deeply oversold scenarios meet a potential production ramp and strategic partnerships that could unlock m...